知镜 Cognispect · 医学文献与研究工作台

SF3B1-mutated MDS coexisting with β-thalassemia trait: A case report and literature review focused on diagnostic distinction from acquired β-thalassemia.

Fang Z, Chen L, Zhao M, Chen X.
Medicine · 2026-10-01 · PMID 42854053

文献摘要

Rationale β-Thalassemia trait and myelodysplastic syndrome (MDS) may occur in the same patient. In patients with MDS and microcytosis, an important diagnostic consideration is whether the thalassemic phenotype represents a preexisting hereditary disorder or an acquired abnormality related to the myeloid clone. We report on a patient with SF3B1-mutated MDS and β-thalassemia trait, supported by longitudinal hematologic and molecular findings, and discuss the diagnostic distinction between these conditions. Patient concerns An 81-year-old male presented with fatigue and fever, and laboratory investigations revealed microcytic anemia. Further evaluation identified SF3B1-mutated MDS with concomitant β-thalassemia trait. Diagnoses The patient was diagnosed with SF3B1-mutated MDS with concomitant β-thalassemia trait based on bone marrow morphology and molecular studies. Interventions and outcomes Following conservative management, the patient was discharged. During the available follow-up period, the patient remained clinically stable across three outpatient visits for complete blood count monitoring. Lessons This case illustrates the importance of distinguishing hereditary β-thalassemia from acquired thalassemic phenotypes in patients with MDS and microcytosis. Longitudinal hematologic history, hemoglobin analysis, and molecular testing can help determine whether microcytosis predates the clonal myeloid disorder. The available case-based literature does not permit a reliable estimate of the prevalence of this co-occurrence or comparison with a control population.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。